Emeis Stock Falls 2.5% and Drops Below Its MM50, Among the Worst in the SBF 120
The health services group's stock significantly declines in early afternoon trading, in a downward trending Parisian market. The stock is among the biggest losers in its reference index, even though it was trading above its short moving averages at the beginning of last week.
The Stock Falls Below the MM50 and Approaches the Support at €13.64
Emeis stock loses 2.41% to €14.15 after a last close at €14.50. The decline erases part of the rebound initiated last week, when the stock moved back above a closely watched technical threshold. The price falls below the MM50 (€14.41), with a gap of 1.80% against the stock, while remaining slightly above the MM20 at €14.06. The RSI at 55 remains neutral, indicating neither overbought nor oversold conditions. The scenario of a new test of the support at €13.64, already tested on June 24, becomes relevant again if the selling pressure continues during the session.
The immediate resistance is identified at €15.11. The stock ranks among the largest declines in the SBF 120, which is down 0.14%. The decline is part of a tumultuous sequence since the beginning of the month, marked by a series of rebounds and tests of the support at €13.64. Over a month, Emeis loses 6.35%, while the performance over three months is still positive at 14.21% and that over one year at 33.49%.
A Decline in a Parisian Market Weighed Down by Caution on Cyclical Stocks
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The CAC 40 loses 0.19% at 8,369 points during the session and the SBF 120 is down 0.14%, in an international context marked by the announced pause between Washington and Tehran on the Ormuz file and by Ukrainian strikes on Russian energy infrastructures. The VIX relaxes to 18.32 points (-3.02%), a sign of a risk aversion that is not worsening overall, even though several Parisian cyclical stocks (Air France-KLM, Vinci, EssilorLuxottica) are alongside Emeis at the bottom of the ranking. The stock's trajectory since autumn 2025 remains supported by the half-yearly results published in early October, which had triggered several sessions of marked increase.
The movement of the day is part of a consolidation phase after the bullish course achieved over the last three months. The next technical milestones to watch remain the support at €13.64 on the downside and the MM50 at €14.41 on the rebound.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
